BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35782084)

  • 41. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
    J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis.
    Liu YX; Yuan S; Liu XJ; Huang YX; Qiu P; Gao J; Deng GP
    J Mol Med (Berl); 2022 Sep; 100(9):1271-1286. PubMed ID: 35788718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long Noncoding RNA
    Dou X; Zhou Q; Wen M; Xu J; Zhu Y; Zhang S; Xu X
    Front Pharmacol; 2019; 10():1700. PubMed ID: 32082174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
    Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
    Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
    Nong Q; Yu S; Hu H; Hu X
    Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
    Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2.
    Meng X; Zhang Y; Hu Y; Zhong J; Jiang C; Zhang H
    Cell Signal; 2021 Oct; 86():110088. PubMed ID: 34265414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.
    Lin Z; Li Y; Shao R; Hu Y; Gao H
    World J Surg Oncol; 2021 Jun; 19(1):163. PubMed ID: 34090483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA FOXD2-AS1 facilitates the progression of hepatocellular carcinoma by regulating TWIST1.
    Chen G; Zhang WL; Zhang SM; Tang KL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4536-4543. PubMed ID: 37259735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis.
    Wei G; Lu T; Shen J; Wang J
    Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA-ZNF252P-AS1/miR-15b-5p promotes the proliferation of keloid fibroblast by regulating the BTF3-STAT3 signaling pathway.
    Guo Y; Li M; Long J; Fan P; Zuo C; Wang Y
    J Dermatol Sci; 2022 Dec; 108(3):146-156. PubMed ID: 36641250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA FOXD2-AS1 accelerates the papillary thyroid cancer progression through regulating the miR-485-5p/KLK7 axis.
    Zhang Y; Hu J; Zhou W; Gao H
    J Cell Biochem; 2019 May; 120(5):7952-7961. PubMed ID: 30456805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
    Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
    Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
    Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
    J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.